We currently have a pilot Phase II approved protocol for previously untreated Stage III or IV asymptomatic, non-bulky Follicular lymphoma, ready for execution and are designing additional protocols for FL utilizing total antigenic repertoire as well as novel neo-antigens.

​

Proposed Principal Investigator:

Principal Investigator TBD (to be determined)

Status: Approved, not started